The complexity of psychiatric and behavioral disorders stems from their multifaceted nature, which affects mood, cognition, and behavior in diverse ways. Disorders like depression, anxiety, and schizophrenia are often influenced by a combination of genetic predisposition, environmental factors, and neurochemical imbalances. Advances in neuroimaging and molecular genetics are allowing researchers to explore the structural and functional brain changes associated with these conditions, offering new opportunities for targeted therapies. Current treatment strategies, including medications and psychotherapy, aim to alleviate symptoms and improve patient quality of life. As research progresses, personalized approaches to mental health care, based on an individual's genetic makeup and environmental influences, are emerging as a promising pathway to more effective treatments.
Title : Perception and individuality
Ken Ware, NeuroPhysics Therapy Institute, Australia
Title : ACE-dependent Alzheimer’s Disease (AD)
Sergei M Danilov, University of Illinois, United States
Title : Essential roles, mechanisms and consequences of vascular dementia
Yong Xiao Wang, Albany Medical College, United States
Title : Neuroimaging by evaluation nerverenovate and neuroplasticity of acupuncture in children with cerebral palsy
Zhenhuan Liu, Guangzhou University of Chinese Medicine, China
Title : The foundation and architecture of Personalized & Precision Medicine (PPM) in clinical neurology: Towards curative and neurodegenerative disease-modifying treatment for multiple sclerosis
Sergey Suchkov, R&D Director of the National Center for Human Photosynthesis, Mexico
Title : Who cares …… for the carers
Jaqueline Tuppen, COGS Club, United Kingdom